Stocks and Investing Stocks and Investing
Fri, September 24, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Andy Barish Upgraded (CAKE) to Strong Buy and Increased Target to $60 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Gabe Hajde Initiated (AMBP) at Buy and Held Target at $14 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Andrew Mok Initiated (AMED) at Strong Sell and Held Target at $150 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Victoria Greer Upgraded (ALV) to Hold and Held Target at $85 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Dane Leone Upgraded (ALLO) to Buy and Held Target at $36 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Matt Koranda Maintained (ATER) at Hold with Increased Target to $144 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Gregory Renza Initiated (AVTX) at Buy on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Andrew Mok Initiated (UHS) at Strong Sell and Held Target at $136 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Dae Gon Ha Initiated (VERV) at Hold and Held Target at $58 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
James Feldman Upgraded (VNO) to Hold on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Arren Cyganovich Upgraded (VLY) to Hold and Increased Target to $14 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Cesar Medina Upgraded (VTEX) to Buy and Held Target at $30 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Adam Josephson Initiated (WPM) at Buy and Held Target at $47 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Andrew Smith Upgraded (TENB) to Strong Buy and Held Target at $55 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Brian Bedell Maintained (STT) at Strong Buy with Decreased Target to $111 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Danielle Antalffy Maintained (TNDM) at Hold with Increased Target to $135 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Whit Mayo Initiated (THC) at Hold and Held Target at $83 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Sophie Karp Upgraded (CNP) to Buy and Held Target at $28 on, Sep 24th, 2021
[ Fri, Sep 24th 2021 ] - WOPRAI
Gabriel Moreen Upgraded (SR) to Strong Buy and Decreased Target to $73 on, Sep 24th, 2021
Thu, September 23, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Clarke Jeffries Maintained (SPT) at Buy with Increased Target to $155 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Scott Berg Maintained (SPT) at Strong Buy with Increased Target to $160 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Toni Kaplan Maintained (SPGI) at Buy with Increased Target to $498 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
John Campbell Maintained (TREE) at Buy with Decreased Target to $265 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Toni Kaplan Maintained (TRI) at Hold with Increased Target to $110 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Meta Marshall Downgraded (TRMB) to Sell and Held Target at $74 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Toni Kaplan Maintained (TRU) at Buy with Increased Target to $131 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Matthew Portillo Initiated (TSLA) at Strong Sell and Held Target at $179 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Chris Dankert Initiated (TKR) at Hold and Held Target at $72 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Doug Schenkel Maintained (TMO) at Buy with Increased Target to $655 on, Sep 23rd, 2021
[ Thu, Sep 23rd 2021 ] - WOPRAI
Zegbeh Jallah Maintained (SYRS) at Strong Buy with Increased Target to $230 on, Sep 23rd, 2021

Zegbeh Jallah Maintained (SYRS) at Strong Buy with Increased Target to $230 on, Sep 23rd, 2021


Published on 2024-10-27 17:59:17 - WOPRAI, Zegbeh Jallah
  Print publication without navigation


Zegbeh Jallah of Roth Capital, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy with Increased Target from $200 to $230 on, Sep 23rd, 2021.

Zegbeh, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources